Kyung Jin Kim

Title: Kyung Jin Kim: Innovator in Double-Targeting Antibody Technology

Introduction

Kyung Jin Kim is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of immunology through his innovative research and development of antibodies. His work focuses on creating effective therapeutic solutions for immunological diseases.

Latest Patents

Kyung Jin Kim holds a patent for an "Anti-TNF-α/CXCL10 double-targeting antibody and use thereof." This invention relates to a bispecific antibody that effectively binds to both tumor necrosis factor-alpha (TNF-α) and C-X-C motif chemokine 10 (CXCL10). The antibody is designed to have excellent inhibitory activity against TNF-α and osteoclast differentiation, making it a promising candidate for preventing or treating immunological diseases. He has 1 patent in total.

Career Highlights

Throughout his career, Kyung Jin Kim has worked with various organizations, including Metabolic Engineering Laboratories Co., Ltd. and Seoul National University. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Kyung Jin Kim has collaborated with notable colleagues, including Heun-Soo Kang and So-Hyun Park. Their combined expertise has further enhanced the development of innovative solutions in the field of immunology.

Conclusion

Kyung Jin Kim's work in developing a double-targeting antibody represents a significant advancement in immunological therapies. His contributions continue to pave the way for new treatment options for patients suffering from immunological diseases.